NO864724L - Fremgangsmaate ved fremstilling av humant somatomedin c. - Google Patents

Fremgangsmaate ved fremstilling av humant somatomedin c.

Info

Publication number
NO864724L
NO864724L NO86864724A NO864724A NO864724L NO 864724 L NO864724 L NO 864724L NO 86864724 A NO86864724 A NO 86864724A NO 864724 A NO864724 A NO 864724A NO 864724 L NO864724 L NO 864724L
Authority
NO
Norway
Prior art keywords
dna sequences
somatomedin
humant
preparing
procedure
Prior art date
Application number
NO86864724A
Other languages
English (en)
Other versions
NO302709B1 (no
Inventor
Gary N Buell
Nageswarao Movva
Original Assignee
Biogen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Nv filed Critical Biogen Nv
Publication of NO864724L publication Critical patent/NO864724L/no
Publication of NO302709B1 publication Critical patent/NO302709B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
NO864724A 1985-03-26 1986-11-25 Fremgangsmåte ved forbedret produksjon av et polypeptid i en vertscelle NO302709B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858507833A GB8507833D0 (en) 1985-03-26 1985-03-26 Production of human somatomedin c
PCT/US1986/000579 WO1986005810A1 (en) 1985-03-26 1986-03-25 Production of human somatomedin c

Publications (2)

Publication Number Publication Date
NO864724L true NO864724L (no) 1987-01-23
NO302709B1 NO302709B1 (no) 1998-04-14

Family

ID=10576658

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864724A NO302709B1 (no) 1985-03-26 1986-11-25 Fremgangsmåte ved forbedret produksjon av et polypeptid i en vertscelle

Country Status (14)

Country Link
EP (1) EP0215110B1 (no)
JP (4) JPH0691832B2 (no)
CN (1) CN1034588C (no)
AT (1) ATE87977T1 (no)
AU (1) AU594950B2 (no)
CA (1) CA1339305C (no)
DE (1) DE3688225T2 (no)
DK (1) DK175223B1 (no)
ES (1) ES8705921A1 (no)
GB (1) GB8507833D0 (no)
IL (1) IL78278A0 (no)
NO (1) NO302709B1 (no)
WO (1) WO1986005810A1 (no)
ZA (1) ZA862240B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221789A (en) * 1986-09-12 1991-05-28 Genentech Inc Recombinant prorelaxin, its preparation and pharmaceutical compositions comprising it
GB8712540D0 (en) * 1987-05-28 1987-07-01 Ucb Sa Expression of human proapolipoprotein a-i
US4876242A (en) * 1987-09-21 1989-10-24 Merck & Co., Inc. Human insulin-like growth factor analoges with reduced binding to serum carrier proteins and their production in yeast
AUPP807899A0 (en) 1999-01-08 1999-02-04 University Of Queensland, The Codon utilization
JP6018719B1 (ja) * 2016-03-15 2016-11-02 Bx新生精機株式会社 シャッター開閉機の巻上装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207842A (en) * 1983-04-25 1988-02-12 Chiron Corp Production of human insulin-like growth factor (igf) using cdna
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
SE8303626D0 (sv) * 1983-06-23 1983-06-23 Kabigen Ab A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced
EP0151760A1 (en) * 1984-01-06 1985-08-21 Takeda Chemical Industries, Ltd. Novel DNA and use thereof
US4758512A (en) * 1984-03-06 1988-07-19 President And Fellows Of Harvard College Hosts and methods for producing recombinant products in high yields

Also Published As

Publication number Publication date
AU594950B2 (en) 1990-03-22
ATE87977T1 (de) 1993-04-15
JPH07143896A (ja) 1995-06-06
JPH07145200A (ja) 1995-06-06
EP0215110A4 (en) 1987-07-09
ES553374A0 (es) 1987-05-16
JPH07102152B2 (ja) 1995-11-08
EP0215110A1 (en) 1987-03-25
ZA862240B (en) 1986-11-26
AU5665786A (en) 1986-10-23
CN1034588C (zh) 1997-04-16
JPH0691832B2 (ja) 1994-11-16
JPH07143885A (ja) 1995-06-06
DK175223B1 (da) 2004-07-12
CA1339305C (en) 1997-08-19
NO302709B1 (no) 1998-04-14
JP2602628B2 (ja) 1997-04-23
GB8507833D0 (en) 1985-05-01
IL78278A0 (en) 1986-07-31
ES8705921A1 (es) 1987-05-16
DK569886D0 (da) 1986-11-26
DK569886A (da) 1986-11-26
JPS62502305A (ja) 1987-09-10
DE3688225T2 (de) 1993-07-22
EP0215110B1 (en) 1993-04-07
WO1986005810A1 (en) 1986-10-09
JP2568383B2 (ja) 1997-01-08
DE3688225D1 (de) 1993-05-13
CN86102889A (zh) 1986-11-26

Similar Documents

Publication Publication Date Title
DE3586189D1 (de) Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute.
DK163683D0 (da) Fremstilling af funktionelle humane urokinaseproteiner, dna-sekvens, der koder for et protein omfattende den enzymatiske del af human urokinase, replicerbart udtrykkelsesmedium, der kan udtrykkedna-sekvensen og mikroorganisme eller cellekultur transformeret med mediet
PL272698A1 (en) Method for expressing human proapolyprotein a-j
DK666888D0 (da) Human vaevsfaktor-relaterende dna-segmenter, polypeptider og antistoffer
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
FI920923A0 (fi) Fusionsproteiner, deras framstaellning samt anvaendning.
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
NO833464L (no) Dna sekvenser, rekombinant dna molekyler og fremgangsmaater ved fremstilling av svinevekst hormonliknende polypeptider
DK491487D0 (da) Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme
DK645887A (da) Gamma-hesteinterferon, fremgangsmaade til fremstilling af, samt anvendelse af en saadan forbindelse
NO864724L (no) Fremgangsmaate ved fremstilling av humant somatomedin c.
KR900700604A (ko) 오이 모자이크 바이러스 코트 단백질 유전자
ZA874677B (en) Dna sequence,recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides,obtained products and preparations containing same
DE3786870D1 (de) Methode zur herstellung von proteinen.
ATE188997T1 (de) Klonierung von malaria-spezifischen dna- sequenzen:isolierung des gens für das 140 kd protein
DK266187A (da) Rekombinant humant protein s, fremgangsmaade til fremstilling heraf og rekombinant dna-vektor til brug ved fremgangsmaaden
Buell et al. Production of human somatomedin C
FI934079A (fi) Menetelmä fuusioproteiinin valmistamiseksi
DK164877A (da) Samlebind
IE871743L (en) "dna sequence, recombinant dna molecules and process for¹producing the newcastle disease virus fusion protein or¹equivalent polypeptides, obtained products and preparations¹containing the same"
ATE83800T1 (de) Rekombinantes dns-plasmid zur herstellung von xanthangummi.